The impact of the women's health initiative study on incident clonidine use in Ontario, Canada

Canadian Journal of Clinical Pharmacology

Volumn 11, Issue 2, 2004, Pages

  Austin, Peter C ^a   Mamdani, Muhammad M ^a   Tu, Karen ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Clonidine; Estrogen replacement therapy; Health services research; Menopause; Pharmacoepidemiology

Indexed keywords

CLONIDINE; ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; CANADA; CONTROLLED STUDY; DATA BASE; DRUG USE; ELDERLY CARE; ESTROGEN THERAPY; FEMALE; HOT FLUSH; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MENOPAUSE; POPULATION BASED CASE CONTROL STUDY; SEX DIFFERENCE; WOMEN'S HEALTH; DRUG UTILIZATION; POSTMENOPAUSE; RETROSPECTIVE STUDY; STATISTICS;

AGED; ANTIHYPERTENSIVE AGENTS; CLONIDINE; DRUG UTILIZATION; FEMALE; HOT FLASHES; HUMANS; MALE; ONTARIO; POSTMENOPAUSE; RETROSPECTIVE STUDIES; WOMEN'S HEALTH;

EID: 33645520561     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Writing Group for the Women's Health Initiative Investigators. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288:321-333.
2. Austin PC, Mamdani MM, Tu K, Jaakkimainen L. Trends in Use of Estrogen Replacement Therapy in Ontario, Canada Following Publication of the Women's Health Initiative Study. Journal of the American Medical Association 2003;289:3241-3242.
3. Andre Picard. Risks prompt many Canadian women to stop hormone replacement therapy. The Globe and Mail Thursday, January 30, 2002; page A7.
4. Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol 1987;156:561-565.
5. Edington RF, Chagnon JP, Steinberg WM. Clonidine (Dixarit) for menopausal flushing. Canadian Medical Association Journal 1980;123:23-26.
6. Clayden JR, Bell JW, Pollard P. Menopausal flushing: Double-blind trial of a non-hormonal medication. British Medical Journal 1974;1:409-412.
7. Schindler AE, Muller D, Keller E, Goser R, Runkel F. Studies with clonidine (dixarit) in menopausal women. Archives of Gynegology 1979;227:341-7.
8. Laufer LR, Erlik Y, Meldrum DR, Judd HL. Effect of clonidine on hot flashes in postmenopausal women. Obstetrics & Gynecology 1982;60:583-6.
9. Wren BG, Brown LB. A double-blind trial with clonidine and a placebo to treat hot flushes. Medical Journal of Australia 1986;144:369-70.
10. Salmi T, Punnonen R. Clonidine in the treatment of menopausal symptoms. International Journal of Gynaecology & Obstetrics 1979;16:422-6.
11. van den Bosch WJ. The Dutch College of General Practitioners practice guideline "The menopause"; reaction from the field of general practice. Nederlands Tijdschrift voor Geneeskunde 2002;146:1309-1310.
12. Lucero MA, McCloskey WW. Alternatives to estrogen for the treatment of hot flashes. Annals of Pharmacotherapy 1997;31:915-7.
13. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and Treatment of Hot Flashes. Mayo Clinic Proceedings 2002;77:1155-8.
14. Canadian Pharmacists Association. Compendium of pharmaceuticals and specialties. 36th ed. Ottawa: The Association; 2001.